[
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Sigma Healthcare, Hartalega, Roche and more in the latest Market Talks covering Health Care.",
    "url": "https://finnhub.io/api/news?id=118598c44e50c2147995d5bbde90416570f7379aafe40894ae0fdd2fe99658de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754301480,
      "headline": "Health Care Roundup: Market Talk",
      "id": 136199238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Find insight on Sigma Healthcare, Hartalega, Roche and more in the latest Market Talks covering Health Care.",
      "url": "https://finnhub.io/api/news?id=118598c44e50c2147995d5bbde90416570f7379aafe40894ae0fdd2fe99658de"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Beat COVID Vaccine Revenue Estimates But Still Lowered 2025 Outlook, RBC Says",
    "summary": "Moderna (MRNA) reported Q2 COVID vaccine revenue of $114 million, topping the $89 million analyst es",
    "url": "https://finnhub.io/api/news?id=d554f1e074c087ddb95bc36fef85c5deb8b9d94937e5b9c4d4b8890b2db88ada",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754320132,
      "headline": "Moderna Beat COVID Vaccine Revenue Estimates But Still Lowered 2025 Outlook, RBC Says",
      "id": 136200763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) reported Q2 COVID vaccine revenue of $114 million, topping the $89 million analyst es",
      "url": "https://finnhub.io/api/news?id=d554f1e074c087ddb95bc36fef85c5deb8b9d94937e5b9c4d4b8890b2db88ada"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish",
    "summary": "Explore Moderna, Inc.'s Q2 2025 earnings, with steep revenue declines and growth challenges. Click for my updated look at MRNA and its latest results.",
    "url": "https://finnhub.io/api/news?id=4fb669cdd9240fd661346c57e4a926ffbcbef8e991e74044b90ac410f68bfda0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754299999,
      "headline": "Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish",
      "id": 136197680,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1423530449/image_1423530449.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Explore Moderna, Inc.'s Q2 2025 earnings, with steep revenue declines and growth challenges. Click for my updated look at MRNA and its latest results.",
      "url": "https://finnhub.io/api/news?id=4fb669cdd9240fd661346c57e4a926ffbcbef8e991e74044b90ac410f68bfda0"
    }
  }
]